The budget is based on a context of fast-paced growth, but with profit margins under pressure.
In 2025, consolidated revenue rose by 16.9%, from RON2.715 billion to RON3.17 billion, driven primarily by the hospital segment, which grew by 33.5% to RON883 million. Clinics added 15.8%, for a total of RON1.184 billion, while laboratories grew by 19.2%. On the other hand, the dental clinic business decreased by 2.6%, reflecting more cautious spending in the premium segment, MedLife said in its annual report.
Consolidated EBITDA stood at RON444.7 million in 2025, with a margin of 14%, and the 2026 budget targets an EBITDA of RON511.9 million, at a slightly higher margin of 14.5%.
Operating profit is estimated to go up 24.5% from RON158.9 million to RON197.8 million. Operating expenses are projected at RON3.34 billion, up 10.3%, a slower rate than revenue growth, hence the improvement in margins.
One item explicitly included in the 2026 consolidated budget is the acquisition of Medstar, the network of clinics in Cluj-Napoca fully acquired through Sfanta Maria and finalized in January 2026. In 2025, the group had also acquired Routine Med in Tulcea and All Clinic in the Republic of Moldova, the latter marking its second international expansion, following its entry into Hungary in 2019. Potential future acquisitions are not reflected in the 2026 budget, the document says.
(English version by Loredana Fratila-Cristescu)